Today Dominic is checking out the Aorus 15 (XE4) gaming laptop. This was originally priced at £2199, but has now had a £450 price cut. Offering an i7-12700H, rtx 3070 Ti and beautiful 1440p screen, we ...

There's a long line of JRPGs whose graphics have aged out with their launch consoles, but these JRPGs have visuals that have ...

The 2026 XC40 is available in B4 and B5 model series with Core, Plus, and Ultra (B5 only) trim levels. Volvo bases the new ...

The retail giant has slashed prices on top-rated big-name brandsFollow live: All the best deals in the January sales ...

Cancer continues to be one of the world's top causes of death, partly because of delayed discovery of the disease. But according to a recently released study, a simple blood test may be able to ...

In my review of the M5 MacBook Pro, the laptop’s graphics performance stood out. It offers a 35 percent boost in Metal performance over the M4, which is significant. It’s also good for Apple’s Mac ...

Starting next month, green card holders seeking to become U.S. citizens will be taking a new and longer version of the naturalization test. The 2025 Naturalization Civics Test will have more potential ...

Nick is a freelance writer from Chicago, IL, with a BA in Creative Writing from the University of Illinois at Urbana-Champaign. His lifelong belief in the artistic power of video games led him to ...

The high-output Cummins diesel engine now makes 430 horsepower and 1,075 lb-ft of torque, an improvement of 30 horses and 75 lb-ft compared to its previous generation. There is also a reworked ZF ...

Nvidia did provide some caveats when handing over a Razer Blade 16 to test. It's a thinner model than previous years—likely one of the thinnest gaming laptops with an RTX 5090 at the least. Razer had ...

The Suikoden I & II HD Remaster has finally arrived, reviving two of the most cherished RPGs from the 90s, offering enhanced graphics, refined gameplay, and an updated soundtrack. Whether you’re a ...

With Eylea biosimilar competition creeping in and Roche’s Vabsymo jockeying for market share in key indications, Regeneron is racing to carve out a new market for the high-dose version of its ...